Optimising patient pathways in rare disease through and beyond the COVID-19…
Gavin Jones, Director of Rare Disease, OPEN Health was in conversation with Peter Rutherford, Global Medical Lead, Orphan Renal Diseases, Vifor Pharma, about the current challenges for the rare disease community, identifying opportunities to drive change and what medical education looks like in the new world.
